FDA approves its first ‘national priority’ drug – a version of the widely used antibiotic Augmentin XR – in double-quick time.

The FDA is reexamining the safety of two approved RSV antibodies for infants, the latest move by the agency to scrutinize approved preventive products used

Eli Lilly will spend $6 billion to build an orforglipron factory in Huntsville, AL, the third of four new US sites the pharma giant plans

The FDA’s investigation of Covid-19 vaccine safety in children has expanded into adults, according to people familiar with the agency’s work — a significant widening

ORLANDO, Fla. — Clinical trials in multiple myeloma continue to rapidly progress, and nowhere was this more apparent than at the American Society of Hematology’s